Faculty profile

Shamir Chandarana

Back to faculty

Clinical Associate ProfessorCumming School of MedicineUniversity of Calgary

Shamir Chandarana

Clinical Associate Professor

Cumming School of Medicine

University of Calgary

Calgary, Alberta, Canada

Supervision signals

Clinical faculty often co-supervise; many graduate programs need a core faculty member as the main supervisor.
12 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

783

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Calgary profile.

Thyroid Cancer

Latest papers

Implementing a Rapid Response Pathway for Anaplastic Thyroid Cancer in a Universal Healthcare System.
Laryngoscope investigative otolaryngology · 2026 · senior author
Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial.
European journal of cancer (Oxford, England : 1990) · 2025
Preoperative Clinical and Tumor Factors Associated With Adjuvant Therapy for Oral Cavity Cancer.
JAMA otolaryngology-- head & neck surgery · 2025

All 21 publications

Latest funding

Co-designing better transitions in care for patients undergoing cancer treatment (CanTiC Tx)
CIHR · 2024 · Co-investigator
$279,225

All 1 grants and awards

21 publications.

Implementing a Rapid Response Pathway for Anaplastic Thyroid Cancer in a Universal Healthcare System.

Ghaznavi S, Mahboubi K, Lamb D, Hawker K, Sauro K, Banerjee R, Hart RD, Ruether D, Box A, Khalil M, Gorombey S, Dort J, Chandarana S

Laryngoscope investigative otolaryngology2026Senior authorOpen Access

DOI: 10.1002/lio2.70360 PMID: 41705015

Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial.

Palma DA, Prisman E, Berthelet E, Tran E, Hamilton S, Wu J, Eskander A, Higgins K, Karam I, Poon I, Husain Z, Enepekides D, Hier M, Richardson K, Mlynarek A, Johnson-Obaseki S, Gaudet M, Bayley A, Dowthwaite S, Jackson JE, Dzienis M, O'Neil J, Chandarana S, Banerjee R, Hart R, Chung J, Tenenholtz T, Le H, Yoo J, Mendez A, Winquist E, Kuruvilla S, Stewart P, Warner A, Mitchell S, Chen J, Parker C, Kwan K, Theurer J, Bahig H, Christopoulos A, Mendez LC, Sathya J, Hammond JA, Read N, Venkatesan V, Fung K, Nichols AC

European journal of cancer (Oxford, England : 1990)202519 citations

DOI: 10.1016/j.ejca.2025.115343 PMID: 40121836

Preoperative Clinical and Tumor Factors Associated With Adjuvant Therapy for Oral Cavity Cancer.

Dayan GS, Bahig H, Colivas J, Eskander A, Johnson-Obaseki S, Chandarana S, de Almeida JR, Nichols AC, Hier M, Belzile M, Avagnina A, Hong X, Gaudet M, Matthews TW, Hart R, Goldstein DP, Hosni A, MacNeil D, Fowler J, Khalil C, Khoury M, Morand G, Sultanem K, Ayad T, Christopoulos A

JAMA otolaryngology-- head & neck surgery20254 citationsOpen Access

DOI: 10.1001/jamaoto.2024.5250 PMID: 40146171

Rurality, Health Care Resource Use, and Care Trajectories in Patients With Head and Neck Cancer.

Thomas A, Dort JC, Nakoneshny SC, Matthews TW, Chandarana S, Hart R, Sauro KM

JAMA network open20251 citationsOpen Access

DOI: 10.1001/jamanetworkopen.2025.4675 PMID: 40227686

Surgical Margin Definition and Assessment in Head and Neck Oncology: A Cross-Sectional Survey of Canadian Head and Neck Surgeons.

Daniel RC, Yan B, Chandarana S, Nichols AC, Eskander A, Enepekides D, Higgins K

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale20245 citationsOpen Access

DOI: 10.1177/19160216241296121 PMID: 39511775

Are there opportunities to improve care as patients transition through the cancer care continuum? A scoping review.

Kersen J, Kurbatfinski S, Thomas A, Ibadin S, Hezam A, Lorenzetti D, Chandarana S, Dort JC, Sauro KM

BMJ open20244 citationsOpen Access

DOI: 10.1136/bmjopen-2023-078210 PMID: 39672587

Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response

Rohit Arora, Christian Cao, Mehul Kumar, Sarthak Sinha, Ayan Chanda, Reid McNeil, Divya Samuel, Rahul K. Arora, Thomas Wayne Matthews, Shamir P. Chandarana, Robert D. Hart, Joseph C. Dort, Jeff A. Biernaskie, Paola E. Neri, Martin D. Hyrcza, Pinaki Bose

Nature Communications2023329 citationsOpen Access

DOI: 10.1038/s41467-023-40271-4 PMID: 37596273

Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity Cancer.

Dayan GS, Bahig H, Johnson-Obaseki S, Eskander A, Hong X, Chandarana S, de Almeida JR, Nichols AC, Hier M, Belzile M, Gaudet M, Dort J, Matthews TW, Hart R, Goldstein DP, Yao CMKL, Hosni A, MacNeil D, Fowler J, Higgins K, Khalil C, Khoury M, Mlynarek AM, Morand G, Sultanem K, Maniakas A, Ayad T, Christopoulos A

JAMA otolaryngology-- head & neck surgery202337 citationsOpen Access

DOI: 10.1001/jamaoto.2023.1936 PMID: 37422839

NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.

Arora R, Haynes L, Kumar M, McNeil R, Ashkani J, Nakoneshny SC, Matthews TW, Chandarana S, Hart RD, Jones SJM, Dort JC, Itani D, Chanda A, Bose P

Cancer gene therapy202334 citationsOpen Access

DOI: 10.1038/s41417-022-00578-8 PMID: 36635327

Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.

Palma DA, Prisman E, Berthelet E, Tran E, Hamilton S, Wu J, Eskander A, Higgins K, Karam I, Poon I, Husain Z, Enepekides D, Hier M, Sultanem K, Richardson K, Mlynarek A, Johnson-Obaseki S, Odell M, Bayley A, Dowthwaite S, Jackson JE, Dzienis M, O'Neil J, Chandarana S, Banerjee R, Hart R, Chung J, Tenenholtz T, Krishnan S, Le H, Yoo J, Mendez A, Winquist E, Kuruvilla S, Stewart P, Warner A, Mitchell S, Chen J, Parker C, Wehrli B, Kwan K, Theurer J, Sathya J, Hammond JA, Read N, Venkatesan V, MacNeil SD, Fung K, Nichols AC

JAMA oncology2022110 citationsOpen Access

DOI: 10.1001/jamaoncol.2022.0615 PMID: 35482348

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Shamir Chandarana

Research

Latest papers

Latest funding

Implementing a Rapid Response Pathway for Anaplastic Thyroid Cancer in a Universal Healthcare System.

Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial.

Preoperative Clinical and Tumor Factors Associated With Adjuvant Therapy for Oral Cavity Cancer.

Rurality, Health Care Resource Use, and Care Trajectories in Patients With Head and Neck Cancer.

Surgical Margin Definition and Assessment in Head and Neck Oncology: A Cross-Sectional Survey of Canadian Head and Neck Surgeons.

Are there opportunities to improve care as patients transition through the cancer care continuum? A scoping review.

Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response

Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity Cancer.

NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.

Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.

Co-designing better transitions in care for patients undergoing cancer treatment (CanTiC Tx)

Frequent collaborators

Joseph Dort

Robert Hart

Khara Sauro

Anthony Nichols

Antoine Eskander

Houda Bahig

Andrew Bayley

John Yoo

Eric Winquist

Danny Enepekides

Julie Theurer

S.Danielle MacNeil

Keith Kwan

Kevin Fung

David Palma

Eitan Prisman

Marc Gaudet

Ali Hosni

Irene Karam

Ian Poon

Kevin Higgins

Tareck Ayad

Rahul Arora

Jeff Chen

Diane Lorenzetti

Bret Wehrli